Renal replacement therapy in critically ill patients with acute renal failure: Does a greater dose improve survival? Commentary

Nature Clinical Practice Nephrology

Volumn 3, Issue 3, 2007, Pages 128-129

  Kellum, John A ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITROGEN; UREA;

ACUTE KIDNEY FAILURE; BLEEDING TENDENCY; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; CONTINUOUS HEMODIAFILTRATION; CONTINUOUS HEMODIALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIALYSATE LEVEL; DISEASE SEVERITY; FLOW RATE; HEMODIALYSIS PATIENT; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; LACTIC ACIDOSIS; MAJOR CLINICAL STUDY; NOTE; OBSERVATIONAL STUDY; OLIGURIA; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; SURVIVAL TIME; TREATMENT OUTCOME; ULTRAFILTRATION; UNIVERSITY HOSPITAL; UREA BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; URINE VOLUME;

EID: 33847316395     PISSN: 17458323     EISSN: 17458331     Source Type: Journal    
DOI: 10.1038/ncpneph0398     Document Type: Note

References (5)

1. Kellum JA et al. (2002) The first international consensus conference on continuous renal replacement therapy. Kidney Int 62: 1855-1863
2. Ronco C et al. (2000) Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356: 26-30
3. Schiffl H et al. (2002) Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 346: 305-310
4. Bouman CS et al. (2002) Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med 30: 2205-2211
5. Bellomo R (2006) Do we know the optimal dose for renal replacement therapy in the intensive care unit? Kidney Int 70: 1202-1204